Battling COVID-19: Sun Pharma evaluating potential of existing products
"We are evaluating the potential of some existing products which can be useful in Covid19 treatment. These include Nafamostat Mesilate and phyto- pharmaceutical,AQCH.Both these products are currently undergoing Phase-2 trials in India," he added.
New Delhi: The pharma industry is at the forefront of the battle against Covid-19 and has responded to this global challenge by ensuring the availability of medicines despite supply chain disruptions, Sun Pharmaceutical Industries Chairman Israel Makov said on Thursday. Clinical trials are being conducted to test the effectiveness of many existing medicines in treating symptoms of Covid-19, he added while addressing the annual general meeting (AGM) of the company.